{"id":48130,"date":"2024-08-05T07:10:02","date_gmt":"2024-08-05T07:10:02","guid":{"rendered":"https:\/\/ibima.eu\/?p=48130"},"modified":"2026-01-05T11:29:20","modified_gmt":"2026-01-05T11:29:20","slug":"maria-isabel-barragan-mallofret","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/maria-isabel-barragan-mallofret\/","title":{"rendered":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET"},"content":{"rendered":"<p>Research profile: R4<\/p>\n<h4 data-start=\"281\" data-end=\"658\"><strong data-start=\"281\" data-end=\"322\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Mar\u00eda Isabel Barrag\u00e1n Mallofret<\/span><\/span><\/strong> es Co-Investigadora Responsable del grupo <strong data-start=\"365\" data-end=\"444\">B-05 \u201cInvestigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica\u201d<\/strong> del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA. Es Investigadora Principal del grupo <strong data-start=\"542\" data-end=\"594\">\u201cTranslational Research in Cancer Immunotherapy\u201d<\/strong> del Centro de Investigaci\u00f3n Oncol\u00f3gica de M\u00e1laga (CIMO, IBIMA).<\/h4>\n<p data-start=\"660\" data-end=\"1316\">Desarroll\u00f3 una etapa internacional de siete a\u00f1os en el <strong data-start=\"715\" data-end=\"756\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Karolinska Institutet<\/span><\/span><\/strong>, financiada por una <strong data-start=\"777\" data-end=\"817\">Marie Curie Career Integration Grant<\/strong>, donde se consolid\u00f3 como l\u00edder de grupo independiente dentro del programa Junior Faculty. Durante este periodo impuls\u00f3 la l\u00ednea de investigaci\u00f3n en <strong data-start=\"966\" data-end=\"988\">farmacoepigen\u00e9tica<\/strong>. En 2018 regres\u00f3 a Espa\u00f1a con una nueva beca Marie Curie y obtuvo una posici\u00f3n consolidada como Investigadora Principal en el Sistema Sanitario P\u00fablico de Andaluc\u00eda, equivalente a la estabilizaci\u00f3n tras un contrato Miguel Servet. Mantiene su afiliaci\u00f3n al Karolinska Institutet como profesora externa y colaboradora cient\u00edfica.<\/p>\n<p data-start=\"1318\" data-end=\"1775\">Cuenta con una formaci\u00f3n y experiencia multidisciplinar en <strong data-start=\"1377\" data-end=\"1446\">Farmacolog\u00eda, Gen\u00e9tica Humana y Epigen\u00e9tica hep\u00e1tica y del c\u00e1ncer<\/strong>. Su investigaci\u00f3n en inmuno-oncolog\u00eda tiene un marcado enfoque traslacional. Se centra en la identificaci\u00f3n de <strong data-start=\"1558\" data-end=\"1599\">predictores de respuesta y pron\u00f3stico<\/strong>, as\u00ed como en el estudio de mecanismos complejos de <strong data-start=\"1651\" data-end=\"1677\">regulaci\u00f3n epigen\u00e9tica<\/strong> implicados en la resistencia a f\u00e1rmacos, con el objetivo de descubrir nuevas dianas terap\u00e9uticas.<\/p>\n<p data-start=\"1777\" data-end=\"2130\">Su liderazgo cient\u00edfico est\u00e1 acreditado mediante el <strong data-start=\"1829\" data-end=\"1847\">Certificado R3<\/strong> de la Agencia Estatal de Investigaci\u00f3n. Presenta una producci\u00f3n cient\u00edfica s\u00f3lida como Investigadora Principal, con <strong data-start=\"1964\" data-end=\"1997\">53 art\u00edculos indexados en WoS<\/strong>, de los cuales <strong data-start=\"2013\" data-end=\"2026\">30 son Q1<\/strong> and <strong data-start=\"2029\" data-end=\"2038\">15 D1<\/strong>, siendo autora principal en 38 publicaciones. Es adem\u00e1s coinventora de <strong data-start=\"2110\" data-end=\"2129\">cuatro patentes<\/strong>.<\/p>\n<p data-start=\"2132\" data-end=\"2528\">Ha obtenido financiaci\u00f3n competitiva continuada, incluyendo proyectos internacionales, con una captaci\u00f3n acumulada superior a <strong data-start=\"2258\" data-end=\"2283\">3,5 millones de euros<\/strong> como Investigadora Principal. Desarrolla una intensa actividad de transferencia del conocimiento a trav\u00e9s de la docencia y la supervisi\u00f3n cient\u00edfica, con la formaci\u00f3n de <strong data-start=\"2454\" data-end=\"2496\">m\u00e1s de 26 estudiantes e investigadores<\/strong> en distintas etapas acad\u00e9micas.<\/p>\n<p data-start=\"2530\" data-end=\"2568\"><strong data-start=\"2530\" data-end=\"2543\">Contact:<\/strong> <a class=\"decorated-link cursor-pointer\" rel=\"noopener\" data-start=\"2544\" data-end=\"2568\">isabel.barragan@ibima.eu<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Perfil investigador\/a: R4 Mar\u00eda Isabel Barrag\u00e1n Mallofret es Co-Investigadora Responsable del grupo B-05 \u201cInvestigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica\u201d del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA. Es Investigadora Principal del grupo \u201cTranslational Research in Cancer Immunotherapy\u201d del Centro de Investigaci\u00f3n Oncol\u00f3gica de M\u00e1laga (CIMO, IBIMA). Desarroll\u00f3 una etapa internacional de siete [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":31744,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2497,2090],"tags":[3106,3032,3107,2747,2230,3105],"class_list":["post-48130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-co-investigadora-responsable-b-05","category-grupo_de_investigacion","tag-b-05","tag-cancer-2","tag-epigenetica","tag-ibima","tag-investigacion","tag-traslacional"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima<\/title>\n<meta name=\"description\" content=\"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/maria-isabel-barragan-mallofret\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima\" \/>\n<meta property=\"og:description\" content=\"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/maria-isabel-barragan-mallofret\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-05T07:10:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-05T11:29:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel-1024x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET\",\"datePublished\":\"2024-08-05T07:10:02+00:00\",\"dateModified\":\"2026-01-05T11:29:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/\"},\"wordCount\":358,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/CIMO2-COIR-M.Isabel.png\",\"keywords\":[\"b-05\",\"cancer\",\"epigenetica\",\"IBIMA\",\"Investigacion\",\"traslacional\"],\"articleSection\":[\"Co-Investigadora Responsable - B-05\",\"Investigadores\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/\",\"name\":\"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/CIMO2-COIR-M.Isabel.png\",\"datePublished\":\"2024-08-05T07:10:02+00:00\",\"dateModified\":\"2026-01-05T11:29:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"description\":\"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/CIMO2-COIR-M.Isabel.png\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/CIMO2-COIR-M.Isabel.png\",\"width\":2048,\"height\":2048,\"caption\":\"Isabel Barrag\u00e1n\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/maria-isabel-barragan-mallofret\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima","description":"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/maria-isabel-barragan-mallofret\/","og_locale":"en_GB","og_type":"article","og_title":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima","og_description":"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica","og_url":"https:\/\/ibima.eu\/en\/maria-isabel-barragan-mallofret\/","og_site_name":"Ibima","article_published_time":"2024-08-05T07:10:02+00:00","article_modified_time":"2026-01-05T11:29:20+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel-1024x1024.png","type":"image\/png"}],"author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET","datePublished":"2024-08-05T07:10:02+00:00","dateModified":"2026-01-05T11:29:20+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/"},"wordCount":358,"commentCount":0,"image":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel.png","keywords":["b-05","cancer","epigenetica","IBIMA","Investigacion","traslacional"],"articleSection":["Co-Investigadora Responsable - B-05","Investigadores"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/","url":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/","name":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel.png","datePublished":"2024-08-05T07:10:02+00:00","dateModified":"2026-01-05T11:29:20+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"description":"Mar\u00eda Isabel Barrag\u00e1n Mallofret es coinvestigadora responsable del grupo Investigaci\u00f3n Traslacional en Inmunoterapia del C\u00e1ncer y Epigen\u00e9tica","breadcrumb":{"@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel.png","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/02\/CIMO2-COIR-M.Isabel.png","width":2048,"height":2048,"caption":"Isabel Barrag\u00e1n"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/maria-isabel-barragan-mallofret\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"MAR\u00cdA ISABEL BARRAG\u00c1N MALLOFRET"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/48130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=48130"}],"version-history":[{"count":3,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/48130\/revisions"}],"predecessor-version":[{"id":59223,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/48130\/revisions\/59223"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media\/31744"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=48130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=48130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=48130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}